SE455201B - Diagnostic technique for e.g. cell detection - Google Patents
Diagnostic technique for e.g. cell detectionInfo
- Publication number
- SE455201B SE455201B SE8200479A SE8200479A SE455201B SE 455201 B SE455201 B SE 455201B SE 8200479 A SE8200479 A SE 8200479A SE 8200479 A SE8200479 A SE 8200479A SE 455201 B SE455201 B SE 455201B
- Authority
- SE
- Sweden
- Prior art keywords
- dna
- rna
- specific
- marker
- fragment
- Prior art date
Links
- 238000001514 detection method Methods 0.000 title description 2
- 238000012631 diagnostic technique Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000009396 hybridization Methods 0.000 claims abstract description 11
- 239000012634 fragment Substances 0.000 claims abstract description 10
- 238000002372 labelling Methods 0.000 claims abstract description 9
- 239000003550 marker Substances 0.000 claims abstract description 6
- 241000894007 species Species 0.000 claims abstract description 5
- 241000700605 Viruses Species 0.000 claims abstract description 3
- 244000005700 microbiome Species 0.000 claims abstract description 3
- 108020004414 DNA Proteins 0.000 claims description 23
- 239000000126 substance Substances 0.000 claims description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 102000053602 DNA Human genes 0.000 claims 7
- 229920002477 rna polymer Polymers 0.000 claims 5
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000011895 specific detection Methods 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 2
- 238000002405 diagnostic procedure Methods 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 239000000523 sample Substances 0.000 description 11
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 101710146739 Enterotoxin Proteins 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000000147 enterotoxin Substances 0.000 description 2
- 231100000655 enterotoxin Toxicity 0.000 description 2
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001524679 Escherichia virus M13 Species 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000011545 carbonate/bicarbonate buffer Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
455 201 eukaryot ursprung. 455 201 eukaryotic origin.
Speciellt lämpliga som markörer är luminol och isoluminol, vilka har for- meln NHZ O O NH 25-ZZ IE IE I NH l o o luminol isoluminol där NH2-gruppen avses att kopplas till olika NH2-grupper på DNA- alterna- tivt RNA-molekylen med hjälp av exempelvis glutaraldehyd eller bensokinon.Particularly suitable as markers are luminol and isoluminol, which have the formula NHZ OO NH 25-ZZ IE IE I NH loo luminol isoluminol where the NH2 group is intended to be linked to different NH2 groups on the DNA-alternative RNA molecule by means of of, for example, glutaraldehyde or benzoquinone.
Efter reaktionen med frisläppt DNA eller RNA från det okända provet och separation av hybridiserad och icke hybridiserad DNA resp RNA, t ex genom filtrering, kan graden av hybridisering uppmätas genom uppmätning av lumi- niscensstyrkan. Då således det märkta DNA- eller RNA-fragmentet är speci- fikt för t ex en given vävnad, cell, mikroorganism eller virus, kan förfa- randet enligt uppfinningen användas för såväl kvalitativ som kvantitativ påvisning av denna vävnad, cell etc.After the reaction with released DNA or RNA from the unknown sample and separation of hybridized and non-hybridized DNA or RNA, for example by filtration, the degree of hybridization can be measured by measuring the luminescence strength. Thus, since the labeled DNA or RNA fragment is specific for, for example, a given tissue, cell, microorganism or virus, the method of the invention can be used for both qualitative and quantitative detection of this tissue, cell, etc.
Genom förfarandet enligt uppfinningen undvikes således de problem, som märkning med radioaktiva isotoper medför.The process according to the invention thus avoids the problems which labeling with radioactive isotopes entails.
Inmärkningsproceduren i förfarandet enligt uppfinningen kan emellertid i vissa fall påverka hybridiseringsreaktionen negativt genom att främmande molekyler införs i DNA-strukturen respektive RNA-strukturen. Denna olä- genhet kan emellertid undanröjas, om den artspecifika DNA-sekvensen respektive RNA-sekvensen skyddas under inmärkningsproceduren genom hybri- disering med den homologa sekvensen, varvid markören binds till omgivande, icke-specifika delar av DNA- eller RNA-molekylen.However, the labeling procedure of the process of the invention may in some cases adversely affect the hybridization reaction by introducing foreign molecules into the DNA structure and the RNA structure, respectively. However, this disadvantage can be eliminated if the species-specific DNA sequence and the RNA sequence, respectively, are protected during the labeling procedure by hybridizing with the homologous sequence, thereby binding the marker to surrounding, non-specific parts of the DNA or RNA molecule.
Uppfinningen kommer nu att närmare åskådliggöras i följande exempel. j! ~.~:nf-'í5dv.\' fw- _ ~:- -..- I-'n-:i 12: 455 201 Exempel 1 Inmärkning av DNA med isoluminol Specifikt DNA (1 pg) resuspenderas i 100 pl 0,1 M fosfatbuffert (pH 6,8), och lösningen upphettas till 95°C i 5 min. Efter avsvalning till rumstem- peratur tillsättes glutaraldehyd (1,25 % slutkonc). Efter 18 tim i rums- temperatur separeras ej DNA-bunden glutaraldehyd genom gelfiltrering, Sephadex G-50 (pasteurpipett) jämviktad med 0,1 M NaCl. Droppvisa frak- tioner (50 pl) tas ut, och fraktion 8-15 hälls samman. Till de sammanför- da fraktionerna 8-15 sätts 25 pg isoluminol och 20 pl av 1 M karbonat- bikarbonat-buffert (pH 9,5). Efter 24 tim i 4°C tillsätts lysin 0,2 M.The invention will now be further illustrated in the following examples. j! ~. ~: nf-'í5dv. \ 'fw- _ ~: - -..- I-'n-: i 12: 455 201 Example 1 Labeling of DNA with isoluminol Specific DNA (1 pg) is resuspended in 100 μl 0 , 1 M phosphate buffer (pH 6.8), and the solution is heated to 95 ° C for 5 min. After cooling to room temperature, glutaraldehyde (1.25% final conc) is added. After 18 hours at room temperature, DNA-bound glutaraldehyde is not separated by gel filtration, Sephadex G-50 (pasteur pipette) equilibrated with 0.1 M NaCl. Drop fractions (50 μl) are taken out, and fractions 8-15 are combined. To the pooled fractions 8-15 are added 25 pg of isoluminol and 20 μl of 1 M carbonate-bicarbonate buffer (pH 9.5). After 24 hours at 4 ° C, 0.2 M lysine is added.
DNA-glutaraldehyd-isoluminol-komplexet skiljs ifrån andra komponenter genom ytterligare en gelfiltrering (som ovan). Fraktionerna 8-15 innehål- ler den isoluminolinmärkta DNA-proben, och detta material används sedan direkt vid hybridisering.The DNA-glutaraldehyde-isoluminol complex is separated from other components by an additional gel filtration (as above). Fractions 8-15 contain the isoluminoline-labeled DNA probe, and this material is then used directly in hybridization.
Hybridisering på nitrocellulosafilter Nitrocellulosafilter fuktas i destillerat vatten och placeras på ett dubbellager torrt filterpapper (Whatman no 3). Bakterieprovet läggs på som en känd volym av en bakteriesuspension i PBS-buffert (fosfatbuffrad natriumklorid) eller ett direktprov från patient, t ex avföringsprov (frågeställning: närvaro av enterotoxinproducerande E. coli).Hybridization on nitrocellulose filters Nitrocellulose filters are moistened in distilled water and placed on a double layer of dry filter paper (Whatman no 3). The bacterial sample is applied as a known volume of a bacterial suspension in PBS buffer (phosphate buffered sodium chloride) or a direct sample from a patient, eg faecal sample (question: presence of enterotoxin-producing E. coli).
När proven torkat in, placeras varje filter på ett dubbellager filterpap-1 per, som mättats med 0,5 M Na0H, och inkuberas 10 min i rumstemperatur.Once the samples have dried, each filter is placed on a double layer of filter paper, saturated with 0.5 M NaOH, and incubated for 10 minutes at room temperature.
Därefter överförs filtren med 1-minuters intervaller till tre successiva neutraliseringar på filterpapper mättade med 1 M Tris (trishydroximetyl- aminometan), pH 7. Slutligen placeras filtren 10 min på filterpapper, som mättas med 1 M Tris, pH 7 och 1,5 M NaCl och lufttorkas därefter. Filtren bakas 2 tim i 80°C under vakuum. Under 15 min prehybridiseras filtren i en lösning bestående av 50 % formamid, 0,75 M NaCl, 0,075 M Na-citrat, 0,1 % SDS (natriumdodecylsulfat), 1 mM EDTA (etylendiamintetraacetat), 0,02 % Ficoll (polymer) (molvikt = 400 000), 0,02 % polyvinylpyrrolidon (molvikt = 360 000) samt 0,02 % bovint serumalbumin. Prehybridiseringen sker i 42°c.The filters are then transferred at 1-minute intervals to three successive neutralizations on filter paper saturated with 1 M Tris (trishydroxymethylaminomethane), pH 7. Finally, the filters are placed for 10 minutes on filter paper, which is saturated with 1 M Tris, pH 7 and 1.5 M NaCl and then air dried. The filters are baked for 2 hours at 80 ° C under vacuum. For 15 minutes, the filters are prehybridized in a solution consisting of 50% formamide, 0.75 M NaCl, 0.075 M Na citrate, 0.1% SDS (sodium dodecyl sulfate), 1 mM EDTA (ethylenediaminetetraacetate), 0.02% Ficoll (polymer) (molecular weight = 400,000), 0.02% polyvinylpyrrolidone (molecular weight = 360,000) and 0.02% bovine serum albumin. The prehybridization takes place at 42 ° C.
Filtren placeras på dubbla filterpapper, som mättats med hybridiserings-' buffert (identisk med prehybridiseringslösningen frånsett att värmedenatu- 455 201 e rerat kaïvtymus DNA 75 pg/m1 tiiïsatts. Detta DNA har sonikerats för att ge DNA-fragment av medeïstorïek 2,5 x 105 daïton). Märkta DNA, s k prob- DNA, denatureras genom inkubering i 95°C under 10 min. Proben (50 P1) späds sedan i 42-gradig hybridiserings1ösning, och ca 100 ui probïösning appiiceras ti11 varje prov på fiïtren. Hybridisering får pågå under 1 tim vid 42°C. Slutïigen tvättas filtren två gånger vid 42°C (30 min/tvätt) i en buffert bestående av 0,75 M NaC1, 0,075 M Na-citrat samt 0,1 % SDS och två gånger i rumstemperatur (15 min/tvätt) med 0,3 M NaC1; 0,03 M Na- citrat. Sedan filtren Iufttorkats, räknas mängden märkt DNA som bundits ti11 provens DNA genom konventioneii kemiïuminiscensanaïys. Typiska re- suïtat ses i tabe11 1.The filters are placed on double filter papers, which are saturated with hybridization buffer (identical to the prehybridization solution except that heat-denatured calyx thymus DNA 75 pg / ml is added. This DNA has been sonicated to give DNA fragments of co-history 2.5 x 105 daïton). Labeled DNA, so-called probe DNA, is denatured by incubation at 95 ° C for 10 minutes. The probe (50 μl) is then diluted in 42-degree hybridization solution, and about 100 μl of probe solution is applied to each sample on the filter. Hybridization is allowed to proceed for 1 hour at 42 ° C. Finally, the filters are washed twice at 42 ° C (30 min / wash) in a buffer consisting of 0.75 M NaCl, 0.075 M Na-citrate and 0.1% SDS and twice at room temperature (15 min / wash) with 0 , 3 M NaCl; 0.03 M Na-citrate. After the filters have been air-dried, the amount of labeled DNA bound to the DNA of the samples by conventional chemistry analysis is counted. Typical results are shown in Table 11 1.
Exempel 2 Skydd vid inmärkning av det aktiva stäiiet för hybridisering 1 pg - fag M13 DNA innehåïiande 200 bp (baspar) specifikt probfragment biandas med 1 pg 200 bp renat probfragment i 0,1 M fosfatbuffert (pH 6,8).Example 2 Protection by labeling the active site for hybridization 1 pg - phage M13 DNA containing 200 bp (base pair) specific probe fragment is mixed with 1 pg 200 bp purified probe fragment in 0.1 M phosphate buffer (pH 6.8).
Lösningen upphettas tiil 9506 i 5 min och får sedan stå i rumstemperatur 10 tim. Proceduren fortsättes enïigt exempei 1. Typiska resu1tat kan ses i tabeii 2.The solution is heated to 9506 for 5 minutes and then allowed to stand at room temperature for 10 hours. The procedure is continued according to Example 1. Typical results can be seen in Table 2.
Tabe11 1 Bunden prob Isoiuminoï (mV) cpm (3H) Antaï bakt/m1 preiiminära värden (jämf) Y. pseudotubercuïosis pan 322 108 670 2400 106 30 323 Y. pseudotubercuïosis koneroii 108 25 168 Tamm 2 Enterotoxinproducerande e. C011' (Brac) 108 045 i 2163 Ej :Tec e. em konmm 108 ss 316 455 201 5 Jämföreïse har skett med märkning med radioaktiva isotoper (3H), och där- vid erhåiïna resuïtat framgår av tabeïierna 1 och 2. Därvid framgår att märkning med kemiïuminiscerande ämnen ger vä1 så goda resul tat, vilket visar att förfarandet enïigt uppfinningen utgör ett gott a1 ternativ tiH den hittiHs använda, radioaktiva metoden utan att vara behäftad med de oïägenheter som den radioaktiva märkningen medför.Tabe11 1 Bound probe Isoiuminoï (mV) cpm (3H) Antaï baked / m1 preliminary values (cf.) Y. pseudotubercuïosis pan 322 108 670 2400 106 30 323 Y. pseudotubercuïosis koneroii 108 25 168 Tamm 2 Enterotoxin-producing e 'C0. 045 i 2163 Ej: Tec e. Em konmm 108 ss 316 455 201 5 Comparison has been made with labeling with radioactive isotopes (3H), and the results obtained are shown in Tables 1 and 2. It is clear that labeling with cheminuminescent substances gives such good results, which shows that the process according to the invention constitutes a good alternative to the radioactive method used hitherto without being encumbered with the disadvantages which the radioactive labeling entails.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8200479A SE455201B (en) | 1982-01-28 | 1982-01-28 | Diagnostic technique for e.g. cell detection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8200479A SE455201B (en) | 1982-01-28 | 1982-01-28 | Diagnostic technique for e.g. cell detection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8200479L SE8200479L (en) | 1983-07-29 |
| SE455201B true SE455201B (en) | 1988-06-27 |
Family
ID=20345857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8200479A SE455201B (en) | 1982-01-28 | 1982-01-28 | Diagnostic technique for e.g. cell detection |
Country Status (1)
| Country | Link |
|---|---|
| SE (1) | SE455201B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0210449A2 (en) | 1985-07-10 | 1987-02-04 | Miles Inc. | Prolonged chemiluminescence |
-
1982
- 1982-01-28 SE SE8200479A patent/SE455201B/en not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0210449A2 (en) | 1985-07-10 | 1987-02-04 | Miles Inc. | Prolonged chemiluminescence |
Also Published As
| Publication number | Publication date |
|---|---|
| SE8200479L (en) | 1983-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4994373A (en) | Method and structures employing chemically-labelled polynucleotide probes | |
| EP0420260B1 (en) | Method and kit for detecting a target nucleic acid using a capture probe bound to a polystyrene support via an intermediary protein. | |
| US5856092A (en) | Detection of a nucleic acid sequence or a change therein | |
| JP2618381B2 (en) | Methods and kits for performing nucleic acid hybridization assays | |
| DE69114023T2 (en) | Water-insoluble reagent, nucleic acid probe, test kit and diagnostic and isolation procedures. | |
| EP0457824B2 (en) | Detection of a nucleic acid sequence or a change therein | |
| US5989817A (en) | Target nucleic acid and capture method | |
| US4751177A (en) | Methods and kits for performing nucleic acid hybridization assays | |
| JP3436538B2 (en) | Improved strand displacement assays and conjugates useful therein | |
| US6060242A (en) | PNA diagnostic methods | |
| US5273882A (en) | Method and kit for performing nucleic acid hybridization assays | |
| US5641630A (en) | Method and kit for performing nucleic acid hybridization assays | |
| JPH07246100A (en) | Nucleic acid detection method | |
| JPH02303489A (en) | Amplification of nucleic acid sequence using random sequence oligonucleotide as primer | |
| JPS60100056A (en) | Method for detecting bacteria using nucleic acid hybridization method | |
| DE3888653T2 (en) | Method and test kit for the detection of a nucleic acid sequence. | |
| JPH03103199A (en) | Nucleic acid detection method | |
| EP0405913A2 (en) | Hydrophobic nucleic acid probe | |
| JPH08501220A (en) | Isolated nucleotide sequence for identification of Neisseria gonorrhoeae | |
| AU607393B2 (en) | Shaped articles, which are provided with coatings, for the binding of substances having a bioaffinity, a process for their preparation, and their use | |
| DE102009032502A1 (en) | Detection of antigens | |
| SE455201B (en) | Diagnostic technique for e.g. cell detection | |
| JP3607327B2 (en) | Rapid detection of single microbial cells | |
| EP0797778B1 (en) | A method for preparing non-proteinaceous strongly negatively charged macrobiomolecules, which are linked to plastic | |
| JP2651317B2 (en) | Nucleic acid detection method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 8200479-7 Effective date: 19920806 Format of ref document f/p: F |